Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 16, 2015
BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 27,...
-
Jan 8, 2015
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2015 earnings conference call on Thursday, February 5, 2015, at 8:00...
-
Jan 7, 2015First-of-its-kind medication management solution for manual IV bolus injections expected to be available commercially in spring 2015
BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared...
-
Jan 7, 2015
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 33(rd) Annual J. P. Morgan Healthcare Conference on...
-
Dec 9, 2014American Association for Respiratory Care (AARC) Presents Award at Annual Congress
LAS VEGAS, Dec. 9, 2014 /PRNewswire/ – CareFusion (NYSE: CFN), a leading global medical technology company, was presented today with the Zenith Award from the American Association for...
-
Dec 8, 2014CareFusion Launches New Innovations For Enhanced Medication Management Across Multiple Care SettingsNew Solutions from Pharmacy to Bedside Help Support Hospitals and Extend to Outpatient Care Settings
ANAHEIM, Calif., Dec. 8, 2014 /PRNewswire/ – At the 49th Annual American Society of Health-system Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition, CareFusion (NYSE:CFN) announced new...
-
Dec 8, 2014
ANAHEIM, Calif., Dec. 8, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, and Medacist Solutions Group, LLC (Medacist), the leader in drug diversion...
- Dec 8, 2014Exhibit Offers Experiential View of BD's Robust Portfolio from Preparation to Administration
BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, is presenting its comprehensive solutions for the hospital pharmacy during the...
-
Dec 8, 2014
Becton, Dickinson and Company (NYSE: BDX) ("BD") and CareFusion Corporation (NYSE: CFN) ("CareFusion") today announced that CareFusion expects to hold a special meeting on January 21, 2015 for...
-
Dec 4, 2014
Becton, Dickinson and Company (NYSE: BDX) ("BD") announced today its intention to offer senior unsecured notes under a shelf registration statement on Form S-3 (File No. 333-183059) on file with...
-
Dec 1, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that the company's presentation at the 26(th) Annual Piper Jaffray Healthcare...
-
Nov 26, 2014BD Honored with Partner of the Year Award for Leading Green Power Use
FRANKLIN LAKES, N.J., November 26, 2014 – BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has received a 2014 Green Power Leadership...
-
Nov 20, 2014
Becton, Dickinson and Company (NYSE: BDX) ("BD") and CareFusion Corporation (NYSE: CFN) ("CareFusion") today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements...
-
Nov 6, 2014Revenue increased 11 percent to $922 million
SAN DIEGO, Nov. 6, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its first quarter of fiscal 2015, ended...
-
Nov 4, 2014-- Reports fourth quarter adjusted diluted earnings per share from continuing operations of $1.68. This represents growth of 13.0 percent on a currency-neutral basis, or 9.1 percent including the unfavorable impact of foreign currency. Reported diluted earnings per share from continuing operations for the fourth quarter were $1.53.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.202 billion for the fourth fiscal quarter ended September 30,...
-
Oct 13, 2014Transaction Advances BD’s Entry into Next Generation Sequencing Market
FRANKLIN LAKES, N.J., October 13, 2014 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a...
-
Oct 5, 2014Combination of Complementary Portfolios Creates Global Leader in Medication Management and Patient Safety Solutions
BD (NYSE: BDX) and CareFusion (NYSE: CFN) announced today a definitive agreement under which BD will acquire CareFusion for $58.00 per share in cash and stock, or a total of $12.2 billion, to...
-
Sep 23, 2014Point-of-care CD4 analysis system tailored to meet the needs of resource-limited settings
BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the World Health Organization (WHO) has issued a...
-
Sep 4, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Morgan Stanley Global Healthcare Conference on Monday,...
-
Aug 8, 2014Sedation Analytics Application Combines Infusion and Ventilator Data to Help Ensure Compliance with Sedation Best Practices for Ventilated Patients
SAN DIEGO, CA, Aug. 8, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, today announced the availability of a new capability on the CareFusion Respiratory Knowledge...
-
Aug 7, 2014Fourth quarter revenue of $1.12 billion, up 24 percent; Fiscal 2014 revenue of $3.84 billion, up 8 percent.
SAN DIEGO, Aug. 7, 2014/PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported results for the quarter and fiscal year ended June 30, 2014,...
-
Aug 6, 2014The only pen needle with patented dual needle shields for enhanced convenience and safety is latest BD innovation for insulin injection
FRANKLIN LAKES, N.J., August 6, 2014 – BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the retail pharmacy...
-
Aug 4, 2014Total Nucleic Acid Reagents Now Available Worldwide - Streamlined Workflow for In-House Developed Assays
BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson, and Company) (NYSE: BDX), announced today the availability of the Total Nucleic Acid (TNA) suite of...
-
Jul 31, 2014ChloraPrep 1 mL Applicator Provides Additional Option to Proven Portfolio of Patient Skin Preparation Products
SAN DIEGO, July 31, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced the launch of its ChloraPrep® 1 mL applicator, the newest addition to...
-
Jul 31, 2014- Announces revenues of $2.157 billion, an increase of 5.1 percent, or 4.6 percent on a foreign currency-neutral basis.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.157 billion for the third fiscal quarter ended June 30, 2014,...
